Clinical case of a 29 weeks pregnant patient with ST-segment elevation myocardial infarction
https://doi.org/10.17802/2306-1278-2023-12-2-183-188
Abstract
Highlights
This clinical case describes the management of a 29 weeks pregnant patient with myocardial infarction. The material will be useful for cardiologists, physicians, obstetricians and gynecologists, and endovascular surgeons.
Abstract
Unavoidable drastic changes in lifestyle due childbirth are pushing women to postpone it to an older age, thus increasing the risk of coronary artery disease (CAD) in pregnant women. This can be a problem not only for patients, but also for specialists. Currently there are 3-6 cases of acute coronary syndrome (ACS) per 100 thousand pregnancies, meaning such cases occur rarely in real clinical practice. Discomfort in the chest area does not directly indicate cardiac problem, so women do not visit cardiologist right away, and thus ACS remains undiagnosed. Besides traditional risk factors for CAD (age, dyslipidemia, smoking, physical inactivity), there are some additional obstetric factors: preeclampsia, thrombophilia and postpartum bleeding. About 40% of patients have myocardial infarction in the third trimester. Atherosclerosis is the most common cause of ACS, with coronary artery spasms, coronary artery dissection and thrombosis following behind. Currently the maternal mortality due to MI has decreased from 20% to 5% due to introduction of the percutaneous coronary intervention (PCI) into the treatment of ACS. There are not enough data on the use of thrombolytics and other medicine in the treatment of CAD, because pharmacological therapy can be dangerous in the early pregnancy at the peak of organogenesis. Moreover, PCI should be used with caution due to harmful effects of radiation on the pregnant woman and the fetus. The main task in later stages of pregnancy is to balance out the risk of stent thrombosis upon discontinuing double antiplatelet therapy and bleeding during childbirth and in the postpartum period. This article describes a clinical case of a 29 weeks pregnant patient with myocardial infarction.
About the Authors
Anastasia Y. Serdechnaya
Regional State Budgetary Healthcare Institution “Altai Regional Cardiological Dispensary”; Federal State Budgetary Educational Institution of Higher Education “Altay State Medical University” of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Cardiologist at the Cardiology Department of Acute Coronary Syndrome, Regional State Budgetary Healthcare Institution “Altai Regional Cardiological Dispensary”, Barnaul, Russian Federation; Assistant at the Department of Cardiology and Cardiovascular Surgery, Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation
Irina A. Sukmanova
Regional State Budgetary Healthcare Institution “Altai Regional Cardiological Dispensary”; Federal State Budgetary Educational Institution of Higher Education “Altay State Medical University” of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
PhD, Head of the Cardiology Department of Acute Coronary Syndrome, Regional State Budgetary Healthcare Institution “Altai Regional Cardiological Dispensary”, Barnaul, Russian Federation; Professor at the Department of Cardiology and Cardiovascular Surgery, Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation
References
1. Roth A, ElkayamU.Acute Myocardial Infarction Associated With Pregnancy. J.of Amer. Coll. of Card. 2008; 52 (3): 171-80. DOI: 10.1016/j.jacc.2008.03.049 5
2. Yusuf Karamermer , Jolien W Roos-Hesselink, Coronary heart disease and pregnancy Future Cardiol. 2007 Sep;3(5):559-67. doi: 10.2217/14796678.3.5.559.
3. 2018 ESC Guidelines for themanagement of cardiovascular diseases during pregnancy (text is available in electronic version doi:10.15829/1560-4071-2019-6-151-228). Russian Journal of Cardiology. 2019;(6):151-228. (In Russ.).
4. Serdechnaya A.Yu., Sukmanova I.A. Modern approaches to the diagnosis and treatment of cardiogenic shock complicating acute myocardial infarction. Cardiovascular Therapy and Prevention. 2020;19(5):2661. (In Russ.).
5. Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E: Thrombolytic therapy in pregnancy. J. Thromb. Thrombolysis 21 (3), 271-276 (2006). doi: 10.1007/s11239-006-5709-z
6. 2018 ESC Guidelines for themanagement of cardiovascular diseases during pregnancy (text is available in electronic version doi:10.15829/1560-4071-2019-6-151-228). Russian Journal of Cardiology. 2019;(6):151-228. (In Russ.)
7. Roberts JM, Catov JM: Aspirin for pre-eclampsia: compelling data on benefit and risk. Lancet 369 (9575), 1765-1766 (2007) DOI: 10.1016/S0140-6736(07)60713-2
8. A.E. van den Bosch, T.P. Ruys, J.W. Roos-Hesselink./ Use and impact of cardiac medi-cation during pregnancy./ Future Cardiol, 11 (2015), pp. 89-100. http://dx.doi.org/10.2217/fca.14.68
9. J.W. Roos-Hesselink, T.P. Ruys, J.I. Stein, et al./Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology/ Eur Heart J, 34 (2013), pp. 657-665. http://dx.doi.org/10.1093/eurheartj/ehs270
10. T.P.E. Ruys, J.W. Roos-Hesselink, A. Puijuan-Domenèch, on behalf of the ROPAC in-vestigators, et al./Is a planned caesarean section in women with cardiac disease benefi-cial?./ Heart, 101 (2015), pp. 530-536. http://dx.doi.org/10.1136/heartjnl-2014-306497
Supplementary files
Review
For citations:
Serdechnaya A.Y., Sukmanova I.A. Clinical case of a 29 weeks pregnant patient with ST-segment elevation myocardial infarction. Complex Issues of Cardiovascular Diseases. 2023;12(2):183-188. (In Russ.) https://doi.org/10.17802/2306-1278-2023-12-2-183-188
Views:
1030
